Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

PepsiCo To Boost Nutrition Portfolio With CytoSport Buyout

Published 02/20/2019, 07:30 AM
Updated 07/09/2023, 06:31 AM

PepsiCo Inc’s (NASDAQ:PEP) quest for innovative and complementary products, amid the mass boycott of carbonated soft drinks ('CSD'), has found a new prospect as it signed a deal to buy the CytoSport business of Hormel Foods Corporation (NYSE:HRL) .

Hormel’s CytoSport business mainly includes the Muscle Milk brand, which should fully complement PepsiCo’s existing brands in the sports nutrition category. Further, PepsiCo’s long-standing distribution deal with CytoSport gives it an edge to own and expand this business.

The transaction, which awaits the satisfaction of customary conditions, is expected to be sealed in 30 to 60 days. However, the terms of the deal remained under covers.

Notably, Hormel’s CytoSport business will be the latest in PepsiCo's acquisitions under the ‘Performance with Purpose’ vision, which encourages health and wellness through cost-effective and environment-friendly beverages.

PepsiCo's shares reacted a little to the buyout news. But it has gained 5.9% in the past year against the industry’s decline of 7.8%. Currently, this beverage and snacking giant carries a Zacks Rank #3 (Hold).



PepsiCo is growing its nutrition brands — including Quaker, Tropicana and Gatorade — to counter headwinds that are arising from soft CSD sales. Further, it is expanding the portfolio of nutritious products in categories such as dairy, hummus and other fresh dips, and baked grain snacks. The company is also focused on broadening the beverage portfolio to include more non-carbonated beverages to decrease its dependence on colas. It has been expanding its value share in a number of fastest-growing categories — including tea, enhanced water and sparkling water. For this, it primarily depends on either innovation or acquisition of new brands.

As part of these efforts, the company acquired Health Warrior Inc. in October 2018. Health Warrior makes plant-based products — including nutrition bars and on-trend offerings. This acquisition expands PepsiCo’s nutrition portfolio, offering additional options to consumers in the nutrition bar category, which is a growing space.

Additionally, the company bought all outstanding shares of SodaStream International Ltd. for a cash outlay of $3.2 billion ($144 per share) in December 2018. The acquisition not only fortifies PepsiCo’s beverage and fast-growing water portfolio — including Aquafina, Lifewtr and more — but also adds at-home refreshment beverage offerings. Further, SodaStream expedites PepsiCo’s highly-nutritious and great-tasting beverage offerings.

Looking for Better-Ranked Soft-Drink Stocks? Check These

Monster Beverage (NASDAQ:MNST) has average long-term EPS growth rate of 16% and it currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Coca-Cola (NYSE:KO) European Partners PLC (NYSE:CCEP) , also a Zacks Rank #2 company, has average long-term EPS growth rate of 8.7%.

Zacks' Top 10 Stocks for 2019

In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-holds for the year?

Who wouldn't? Our annual Top 10s have beaten the market with amazing regularity. In 2018, while the market dropped -5.2%, the portfolio scored well into double-digits overall with individual stocks rising as high as +61.5%. And from 2012-2017, while the market boomed +126.3, Zacks' Top 10s reached an even more sensational +181.9%.

See Latest Stocks Today >>

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Monster Beverage Corporation (MNST): Free Stock Analysis Report

Pepsico, Inc. (PEP): Free Stock Analysis Report

Hormel Foods Corporation (HRL): Free Stock Analysis Report

Coca-Cola European Partners PLC (CCEP): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.